Strattera note: As of November 2023, drug manufacturer Eli Lilly and Company discontinued all strengths of Strattera from the marketplace. Strattera generic, atomoxetine, is available.
Strattera (generic for atomoxetine-Sorbencex)
Strattera is made by Pfizer, a pharmaceutical company. It was the first medication approved for the treatment of ADHD in the United States. The active ingredient in Strattera isAdderall®. Strattera is a US- manufactured anti-anxiety medication.
Strattera is prescribed to treat the:
The following are the most common Strattera side effects include:
Strattera:
Talk to your doctor before taking this medicine if you:
Have:- An enlarged prostate - Older adults may experience constipation - Younger patients may experience an enlarged prostate
- Liver disease - Afrin may cause low blood sugar -ukemia may cause a prolonged reaction -nervousness -vierne toxicity
-tteniousness
Tell your pharmacist about all the medicines you take
Strattera is commonly associated with cardiovascular issues like heart attacks and blood clots. These heart problems can be life-threatening and can be life-threatening if left untreated. Pfizer has
that: “The prevalence of heart problems by the
Contains a link to drug overdose, bipolar disorder, and depression. The link between Strattera and Strattera may require emergency departments’ awareness of the underlying cause.”
Both Strattera and its generic equivalent, atomoxetine, have been shown to benefit many patients.
Strattera
Learn more
Atributes.Atomoxetineis a brand of the medication known by the generic nameStrattera. It is a medication primarily used to treat Attention Deficit Hyperactivity Disorder (ADHD), a common psychiatric disorder characterized by a persistent inability to focus on or complete tasks in front of people in their early-to-middle-age years. The exact mechanism of action of atomoxetine is not fully understood. However, it is believed that it enhances the brain's ability to relax, which can help people with ADHD to perform better, stay engaged, and avoid distractions.
Strattera is primarily prescribed for ADHD management. It works by inhibiting the reuptake of norepinephrine and dopamine, two neurotransmitters that play significant roles in regulating attention, focus, and motivation. In clinical settings, atomoxetine is often prescribed as monotherapy or adjunctive therapy. It is also used in individuals with ADHD who struggle with hyperactivity in their early-to middle-age years.
Atomoxetine works by inhibiting the reuptake of norepinephrine and dopamine, which are neurotransmitters involved in attention and cognitive functions. By doing so, it increases the levels of norepinephrine in the brain, which helps improve focus and reduce impulsiveness in those with ADHD.
Strattera can cause side effects, which are generally mild and manageable. These side effects may include drowsiness, dizziness, dry mouth, constipation, and increased heart rate. More serious side effects, which can include suicidal thoughts or behaviors, may occur. It is important to discuss any concerns with a healthcare provider if these side effects persist or worsen.
Strattera should not be used by individuals with a history of cardiovascular disease or a history of allergic reactions. It should not be taken by individuals with a history of an eating disorder or substance abuse disorder.
While atomoxetine is generally well-tolerated, it can have potential side effects. Common side effects may include:
If you experience any of these side effects, it is important to talk to your healthcare provider.
Strattera should be taken with a full glass of water. It is recommended to avoid excessive alcohol consumption as it can increase the risk of side effects. Additionally, it should be swallowed whole with a full glass of water, making it easier to absorb the medication. It is important to follow the prescribed dosage and directions carefully to ensure the medication is effective.
It is important to discuss any potential interactions with other medications with your healthcare provider. They can help determine the appropriate dose and monitor for side effects.
Atomoxetine HCL, commonly known by its brand name Strattera, is a non-stimulant medication prescribed to treat Attention-Deficit Hyperactivity Disorder (ADHD). It works by increasing the levels of norepinephrine in the brain, which helps improve attention, focus, and impulse control[2].
The global Atomoxetine HCL API market is experiencing significant growth, driven by several key factors:
North America is expected to play a crucial role in the Atomoxetine HCL market with a dominant market with projections of around USD,�2017-2023. This is due to high demand for effective ADHD medication, including Atomoxetine HCL[1][3].
The Asia-Pacific region is a key market due to its proximity to the global well-known cities, clinch the attention and hyperactivity, and is expected to grow at a Compound Annual Growth Rate (CAGR) of 4.5% from 2023 to 2028. This growth is driven by rising awareness cases, improved infrastructure + technology, and rising healthcare expenditure[3].
The Asia-PacificoleitntonunciScripte (OST) is a significant player in the North American Atomoxetine HCL market with a dominant market with projections of 40. In 2023, North America was the dominant region with 40. OSTEAM (osteoporotics-associated premature ejaculation) predicted that the market could reach USD 642.6 million[2].
A range of players in the Atomoxetine HCL market includeatonin Pharmaceuticals, Amneal Pharmaceuticals, Johnson & Johnson, Mirape Pharma, Sun Pharmaceutical Industries, Zydus Cadila, Almirall, Torrent Pharmaceuticals, Taro Pharma, Zydus Cadila, Hikma Pharmaceuticals, Lupin, Eli Lilly & Company, Novartis
What are the key players in the Atomoxetine HCL API Market?Quimica is a name that has been used since the late 1990s, with a high success rate due to their high bio-��grade norepinephrine levels. The Quimica name comes from the slang phraseQuimica Quimril (pronunciation: Quimic-eli-il), which is a corruption of the English word QUIMQOL because of the words “excess” and “excess” and “excess” because of the pronunciation of the medication[2].
Product details
Strattera Strattera, the drug for attention-deficit hyperactivity disorder (ADHD), is approved by the FDA to treat ADHD in adults and children (ages 13 to 17 years old). It is available in the US and Europe due to its effectiveness, affordability, and safety profile. The drug is most often prescribed for the treatment of ADHD symptoms in adults and children.
How to use Strattera
The recommended dose of Strattera is one tablet three times a day. Do not exceed the recommended dose.
Take the tablet with a full glass of water.
The tablet should be swallowed whole with a full glass of water.
Do not chew, crush, or open the tablet.
The tablet should not be taken with food.
The tablet may be taken with or without food.
Swallow the tablet whole. Do not chew or crush the tablet.
The dose may be increased or decreased based on the severity of the symptoms.
The maximum recommended dosing frequency is once per day.
The effect of the drug can last for up to 12 weeks. Continue to take the drug for the full 12-week period.
Precautions
Do not use Strattera if you have had an allergic reaction to methylphenidate (Ritalin), amphetamine (Adderall), or methylphenidate with other stimulant medications such as stimulants or monoamine oxidase inhibitors (MAOIs).
Tell your doctor or dentist about all the products you use, including vitamins, minerals, herbal supplements, or recreational drugs.
If you are pregnant or breastfeeding, think you may be pregnant, or are nursing, ask your doctor or pharmacist for advice before taking Strattera.
It may harm your unborn baby. Ask your doctor about using an excipients for the tablets.
Active ingredients
Strattera belongs to a class of medications called atypical antidepressants. It is used to treat attention-deficit/hyperactivity disorder (ADHD) in adults. It works by increasing the amount of norepinephrine and dopamine in the brain.
The drug is most often prescribed to treat ADHD symptoms in adults and children (ages 13 to 17 years old). The drug is most often prescribed for the treatment of ADHD symptoms in adults and children (ages 13 to 17 years old).
Contraindications
Before taking Strattera,
you are allergic to Atomoxetine or any other ingredients in Strattera
you have severe heart, liver, kidney, or bowel problems, or take other medications known as MAOIs
you have a history of seizures or other abnormal EEG changes, including partial or full-thickness mania, ataxia (loss of muscle tone), or tardive dyskinesia (loss of muscle tone)
you have severe liver or kidney problems, or you have a history of liver disease
you have severe vision or hearing problems or a rare condition called NAION
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medications. Strattera may affect how well it works in children. Your doctor will probably start you on a higher dose and increase it slowly over the first few months of treatment.
Tell your doctor if you are taking Strattera to treat an enlarged prostate (benign prostatic hyperplasia).
Tell your doctor if you are taking Strattera to treat an irregular heartbeat (arrhythmias).
Tell your doctor if you have or have ever had serious allergies to any other medications, foods, dyes, or preservatives.
If you have or have ever had a rare condition that causes you to have difficulty breathing, such as severe asthma, severe liver disease, stroke, heart disease, seizures, or seizures with an underlying medical condition, you should not take Strattera.
Stade de France Pharmacy